Elekta AB (publ) (OTCMKTS:EKTAY) was the target of a large growth in short interest during the month of December. As of December 31st, there was short interest totalling 2,400 shares, a growth of 200.0% from the December 15th total of 800 shares. Based on an average trading volume of 4,700 shares, the short-interest ratio is presently 0.5 days.
EKTAY stock traded up $0.25 during trading on Wednesday, reaching $13.39. 1,059 shares of the stock were exchanged, compared to its average volume of 6,170. The firm’s 50 day moving average is $13.22 and its 200 day moving average is $12.09. Elekta AB has a twelve month low of $6.25 and a twelve month high of $13.95. The firm has a market cap of $5.11 billion, a P/E ratio of 39.00 and a beta of 0.85.
EKTAY has been the topic of a number of research reports. JPMorgan Chase & Co. restated a “neutral” rating on shares of Elekta AB (publ) in a research report on Friday, November 27th. They noted that the move was a valuation call. Northland Securities started coverage on Elekta AB (publ) in a research note on Thursday, January 7th. They issued an “outperform” rating on the stock. Morgan Stanley downgraded Elekta AB (publ) from an “equal weight” rating to an “underweight” rating in a research note on Wednesday, December 9th. Finally, Zacks Investment Research downgraded Elekta AB (publ) from a “buy” rating to a “hold” rating in a research note on Wednesday. One analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $15.00.
Elekta AB (publ), a medical technology company, provides clinical solutions for cancer and brain disorders worldwide. The company offers radiotherapy treatment systems, such as Versa HD, a dose delivery accuracy system; Elekta Infinity, an image-guided radiation therapy (IGRT) system; and Elekta Synergy, a digital accelerator for advanced IGRT.
Further Reading: What are municipal bonds?
Receive News & Ratings for Elekta AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elekta AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.